SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2qe6'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EE2_A_CHDA1150_0 (ALCOHOL DEHYDROGENASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 11	LEU A 169 LEU A 81 MET A 165 VAL A 177 ILE A 142	None None SAM A 400 (-3.3A) None None	1.38A	1ee2A-2qe6A: 4.2	1ee2A-2qe6A: 22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HSG_B_MK1B902_2 (HIV-1 PROTEASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	ASP A 110 GLY A 86 ASP A 82 VAL A 136 GLY A 164	SAM A 400 (-2.7A) SAM A 400 ( 3.2A) None SAM A 400 (-3.8A) SAM A 400 (-3.5A)	0.91A	1hsgB-2qe6A: undetectable	1hsgB-2qe6A: 17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1K6C_B_MK1B902_2 (POL POLYPROTEIN)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	ASP A 110 GLY A 86 ASP A 82 VAL A 136 GLY A 164	SAM A 400 (-2.7A) SAM A 400 ( 3.2A) None SAM A 400 (-3.8A) SAM A 400 (-3.5A)	0.98A	1k6cB-2qe6A: undetectable	1k6cB-2qe6A: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QAO_A_SAMA245_0 (ERMC' METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ILE A 111 ASP A 112 ASP A 135	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) None SAM A 400 (-3.4A)	0.38A	1qaoA-2qe6A: 8.2	1qaoA-2qe6A: 20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RI4_A_SAMA299_0 (MRNA CAPPING ENZYME)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ILE A 111 ASP A 135 TYR A 168	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) SAM A 400 (-3.4A) SAM A 400 ( 4.5A)	0.60A	1ri4A-2qe6A: 13.7	1ri4A-2qe6A: 24.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2G72_B_SAMB2002_1 (PHENYLETHANOLAMINE N-METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 7	TYR A 26 GLY A 86 ASP A 110 ASP A 135	SAM A 400 ( 3.8A) SAM A 400 ( 3.2A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.59A	2g72B-2qe6A: 13.3	2g72B-2qe6A: 25.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NXE_A_SAMA302_0 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	ASP A 82 GLY A 84 GLY A 86 ILE A 111 ASP A 112	None SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) None	0.49A	2nxeA-2qe6A: 11.7	2nxeA-2qe6A: 25.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NXE_A_SAMA302_0 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	ASP A 82 LEU A 83 GLY A 84 GLY A 86 ASP A 112	None None SAM A 400 (-3.4A) SAM A 400 ( 3.2A) None	0.75A	2nxeA-2qe6A: 11.7	2nxeA-2qe6A: 25.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NXE_A_SAMA302_0 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	ASP A 82 LEU A 83 GLY A 84 GLY A 86 LEU A 169	None None SAM A 400 (-3.4A) SAM A 400 ( 3.2A) None	0.80A	2nxeA-2qe6A: 11.7	2nxeA-2qe6A: 25.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NXE_B_SAMB303_0 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	ASP A 82 GLY A 84 GLY A 86 ILE A 111 ASP A 112	None SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) None	0.55A	2nxeB-2qe6A: 11.7	2nxeB-2qe6A: 25.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QE6_A_SAMA400_0 (UNCHARACTERIZED PROTEIN TFU_2867)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	12 / 12	ILE A 22 ALA A 23 TYR A 26 GLY A 84 GLY A 86 ILE A 111 ASP A 135 VAL A 136 ARG A 137 VAL A 163 GLY A 164 TYR A 168	SAM A 400 ( 3.7A) SAM A 400 (-3.1A) SAM A 400 ( 3.8A) SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) SAM A 400 (-3.4A) SAM A 400 (-3.8A) SAM A 400 (-4.6A) SAM A 400 (-4.2A) SAM A 400 (-3.5A) SAM A 400 ( 4.5A)	0.21A	2qe6A-2qe6A: 51.6	2qe6A-2qe6A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QE6_A_SAMA400_1 (UNCHARACTERIZED PROTEIN TFU_2867)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	3 / 3	ASN A 60 ARG A 61 ASP A 110	SAM A 400 ( 3.5A) SAM A 400 (-3.7A) SAM A 400 (-2.7A)	0.00A	2qe6A-2qe6A: 51.6	2qe6A-2qe6A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QE6_B_SAMB400_0 (UNCHARACTERIZED PROTEIN TFU_2867)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	12 / 12	ILE A 22 ALA A 23 TYR A 26 GLY A 84 GLY A 86 ILE A 111 ASP A 135 VAL A 136 ARG A 137 VAL A 163 GLY A 164 TYR A 168	SAM A 400 ( 3.7A) SAM A 400 (-3.1A) SAM A 400 ( 3.8A) SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) SAM A 400 (-3.4A) SAM A 400 (-3.8A) SAM A 400 (-4.6A) SAM A 400 (-4.2A) SAM A 400 (-3.5A) SAM A 400 ( 4.5A)	0.11A	2qe6B-2qe6A: 49.4	2qe6B-2qe6A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QE6_B_SAMB400_1 (UNCHARACTERIZED PROTEIN TFU_2867)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	3 / 3	ASN A 60 ARG A 61 ASP A 110	SAM A 400 ( 3.5A) SAM A 400 (-3.7A) SAM A 400 (-2.7A)	0.10A	2qe6B-2qe6A: 49.4	2qe6B-2qe6A: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2UYQ_A_SAMA1311_0 (HYPOTHETICAL PROTEIN ML2640)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 7	GLY A 86 ASP A 110 ASP A 135 ARG A 137	SAM A 400 ( 3.2A) SAM A 400 (-2.7A) SAM A 400 (-3.4A) SAM A 400 (-4.6A)	0.47A	2uyqA-2qe6A: 16.9	2uyqA-2qe6A: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_B_HSMB1160_1 (ALLERGEN ARG R 1)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 7	VAL A 177 TYR A 181 ILE A 142 ASP A 135	None None None SAM A 400 (-3.4A)	1.11A	2x45B-2qe6A: undetectable	2x45B-2qe6A: 19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_C_HSMC1160_1 (ALLERGEN ARG R 1)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 7	VAL A 177 TYR A 181 ILE A 142 ASP A 135	None None None SAM A 400 (-3.4A)	1.11A	2x45C-2qe6A: undetectable	2x45C-2qe6A: 19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YQZ_A_SAMA301_0 (HYPOTHETICAL PROTEIN TTHA0223)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ASP A 112 ARG A 137 VAL A 163	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) None SAM A 400 (-4.6A) SAM A 400 (-4.2A)	0.68A	2yqzA-2qe6A: 9.9	2yqzA-2qe6A: 25.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZZN_A_SAMA401_0 (UNCHARACTERIZED PROTEIN MJ0883)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	TYR A 26 GLY A 86 ILE A 111 ASP A 135 VAL A 136	SAM A 400 ( 3.8A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) SAM A 400 (-3.4A) SAM A 400 (-3.8A)	0.91A	2zznA-2qe6A: 10.4	2zznA-2qe6A: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AY0_A_ADNA401_1 (UNCHARACTERIZED PROTEIN MJ0883)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 10	TYR A 26 ASP A 110 ILE A 111 ASP A 135 VAL A 136	SAM A 400 ( 3.8A) SAM A 400 (-2.7A) SAM A 400 (-3.7A) SAM A 400 (-3.4A) SAM A 400 (-3.8A)	0.95A	3ay0A-2qe6A: 3.5	3ay0A-2qe6A: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AY0_B_ADNB402_1 (UNCHARACTERIZED PROTEIN MJ0883)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	6 / 10	TYR A 26 GLY A 86 ASP A 110 ILE A 111 ASP A 135 VAL A 136	SAM A 400 ( 3.8A) SAM A 400 ( 3.2A) SAM A 400 (-2.7A) SAM A 400 (-3.7A) SAM A 400 (-3.4A) SAM A 400 (-3.8A)	1.06A	3ay0B-2qe6A: 7.2	3ay0B-2qe6A: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BU1_A_HSMA301_1 (LIPOCALIN)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 7	VAL A 177 TYR A 181 ILE A 142 ASP A 135	None None None SAM A 400 (-3.4A)	1.05A	3bu1A-2qe6A: undetectable	3bu1A-2qe6A: 22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CJT_C_SAMC302_0 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	ASP A 82 GLY A 84 ASP A 110 ILE A 111 ASP A 112	None SAM A 400 (-3.4A) SAM A 400 (-2.7A) SAM A 400 (-3.7A) None	0.44A	3cjtC-2qe6A: 12.0	3cjtC-2qe6A: 25.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DZY_A_9CRA463_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	ILE A 160 PHE A 154 LEU A 185 ALA A 186 VAL A 136	None None None None SAM A 400 (-3.8A)	1.05A	3dzyA-2qe6A: undetectable	3dzyA-2qe6A: 19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKT_B_017B200_1 (PROTEASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 9	ASP A 110 GLY A 86 ASP A 82 VAL A 136 GLY A 164	SAM A 400 (-2.7A) SAM A 400 ( 3.2A) None SAM A 400 (-3.8A) SAM A 400 (-3.5A)	1.03A	3ektA-2qe6A: undetectable	3ektA-2qe6A: 17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GRV_A_ADNA300_1 (DIMETHYLADENOSINE TRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 11	GLY A 84 GLY A 86 ILE A 111 ASP A 112 ASP A 135	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) None SAM A 400 (-3.4A)	0.71A	3grvA-2qe6A: 9.3	3grvA-2qe6A: 22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3O7W_A_SAMA801_0 (LEUCINE CARBOXYL METHYLTRANSFERASE 1)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ASP A 135 ARG A 137 TYR A 168	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.4A) SAM A 400 (-4.6A) SAM A 400 ( 4.5A)	0.39A	3o7wA-2qe6A: 16.1	3o7wA-2qe6A: 24.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU6_B_SAMB300_1 (SAM-DEPENDENT METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	3 / 3	TYR A 26 ASP A 110 ASP A 135	SAM A 400 ( 3.8A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.70A	3ou6B-2qe6A: 13.4	3ou6B-2qe6A: 23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU6_C_SAMC300_1 (SAM-DEPENDENT METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	3 / 3	TYR A 26 GLY A 86 ASP A 110	SAM A 400 ( 3.8A) SAM A 400 ( 3.2A) SAM A 400 (-2.7A)	0.72A	3ou6C-2qe6A: 13.3	3ou6C-2qe6A: 23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU7_C_SAMC300_1 (SAM-DEPENDENT METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	3 / 3	GLY A 86 ASP A 110 ASP A 135	SAM A 400 ( 3.2A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.33A	3ou7C-2qe6A: 13.2	3ou7C-2qe6A: 23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXW_B_017B200_1 (HIV-1 PROTEASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 10	ASP A 110 GLY A 86 ASP A 82 VAL A 136 GLY A 164	SAM A 400 (-2.7A) SAM A 400 ( 3.2A) None SAM A 400 (-3.8A) SAM A 400 (-3.5A)	0.97A	3oxwA-2qe6A: undetectable	3oxwA-2qe6A: 15.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SJ4_X_DXCX75_0 (CYTOCHROME C7)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 9	ILE A 160 LEU A 185 ILE A 268 PHE A 233 GLY A 231	None	1.16A	3sj4X-2qe6A: undetectable	3sj4X-2qe6A: 12.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V8V_B_SAMB801_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 11	GLY A 86 ASP A 110 ASP A 112 ASP A 135 VAL A 136	SAM A 400 ( 3.2A) SAM A 400 (-2.7A) None SAM A 400 (-3.4A) SAM A 400 (-3.8A)	0.86A	3v8vB-2qe6A: 10.1	3v8vB-2qe6A: 17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DQC_A_017A101_2 (ASPARTYL PROTEASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 9	ASP A 110 GLY A 86 ASP A 82 VAL A 136 GLY A 164	SAM A 400 (-2.7A) SAM A 400 ( 3.2A) None SAM A 400 (-3.8A) SAM A 400 (-3.5A)	1.00A	4dqcB-2qe6A: undetectable	4dqcB-2qe6A: 16.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HB8_A_DXCA75_0 (PPCA)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 8	ILE A 160 LEU A 185 ILE A 268 PHE A 233 GLY A 231	None	1.25A	4hb8A-2qe6A: undetectable	4hb8A-2qe6A: 11.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IV0_A_SAMA302_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE, PUTATIVE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	VAL A 148 GLY A 84 ILE A 160 ARG A 137 LEU A 143	None SAM A 400 (-3.4A) None SAM A 400 (-4.6A) None	1.04A	4iv0A-2qe6A: 14.2	4iv0A-2qe6A: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IV8_A_SAMA301_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE, PUTATIVE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ASP A 110 ILE A 111 ASP A 135	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-2.7A) SAM A 400 (-3.7A) SAM A 400 (-3.4A)	0.47A	4iv8A-2qe6A: 14.1	4iv8A-2qe6A: 22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IV8_B_SAMB301_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE, PUTATIVE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ASP A 110 ILE A 111 ASP A 135	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-2.7A) SAM A 400 (-3.7A) SAM A 400 (-3.4A)	0.48A	4iv8B-2qe6A: 14.1	4iv8B-2qe6A: 22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KIC_A_SAMA401_0 (METHYLTRANSFERASE MPPJ)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ILE A 111 ARG A 137 MET A 165	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) SAM A 400 (-4.6A) SAM A 400 (-3.3A)	0.66A	4kicA-2qe6A: 15.0	4kicA-2qe6A: 24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KIC_B_SAMB401_0 (METHYLTRANSFERASE MPPJ)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ILE A 111 ARG A 137 MET A 165	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-3.7A) SAM A 400 (-4.6A) SAM A 400 (-3.3A)	0.65A	4kicB-2qe6A: 15.2	4kicB-2qe6A: 24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LB2_A_DM5A602_1 (SERUM ALBUMIN)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 7	PRO A 238 VAL A 241 ALA A 266 TYR A 190	None	0.89A	4lb2A-2qe6A: undetectable	4lb2A-2qe6A: 18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MA7_A_P2ZA301_1 (MAJOR PRION PROTEIN)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 8	VAL A 109 LEU A 83 TYR A 181 VAL A 173	None	0.98A	4ma7A-2qe6A: undetectable	4ma7A-2qe6A: 17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MBS_B_MRVB1101_2 (CHIMERA PROTEIN OF C-C CHEMOKINE RECEPTOR TYPE 5 AND RUBREDOXIN)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 5	TYR A 26 THR A 129 LEU A 123 MET A 114	SAM A 400 ( 3.8A) None MPD A 403 (-4.2A) None	1.21A	4mbsB-2qe6A: undetectable	4mbsB-2qe6A: 21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MWZ_B_SAMB301_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE, PUTATIVE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	VAL A 148 GLY A 84 ILE A 160 ARG A 137 LEU A 143	None SAM A 400 (-3.4A) None SAM A 400 (-4.6A) None	1.05A	4mwzB-2qe6A: 14.0	4mwzB-2qe6A: 20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJT_B_017B101_2 (PROTEASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 10	ASP A 110 GLY A 86 ASP A 82 VAL A 136 GLY A 164	SAM A 400 (-2.7A) SAM A 400 ( 3.2A) None SAM A 400 (-3.8A) SAM A 400 (-3.5A)	1.01A	4njtB-2qe6A: undetectable	4njtB-2qe6A: 16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PGH_B_SAMB401_0 (CAFFEIC ACID O-METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	ASP A 82 GLY A 84 THR A 93 ASP A 110 ASP A 135	None SAM A 400 (-3.4A) None SAM A 400 (-2.7A) SAM A 400 (-3.4A)	1.18A	4pghB-2qe6A: 12.5	4pghB-2qe6A: 22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_2 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 4	GLY A 164 LEU A 71 PHE A 70 ILE A 268	SAM A 400 (-3.5A) None None None	0.80A	4xv2A-2qe6A: undetectable	4xv2A-2qe6A: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YB6_A_HISA302_0 (ATP PHOSPHORIBOSYLTRANSF ERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 10	GLY A 179 VAL A 177 VAL A 178 LEU A 143 LEU A 162	None	1.26A	4yb6A-2qe6A: undetectable 4yb6E-2qe6A: undetectable	4yb6A-2qe6A: 23.31 4yb6E-2qe6A: 23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YB6_B_HISB302_0 (ATP PHOSPHORIBOSYLTRANSF ERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 10	GLY A 179 VAL A 177 VAL A 178 LEU A 143 LEU A 162	None	1.27A	4yb6B-2qe6A: undetectable 4yb6C-2qe6A: undetectable	4yb6B-2qe6A: 23.31 4yb6C-2qe6A: 23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YB6_F_HISF302_0 (ATP PHOSPHORIBOSYLTRANSF ERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 10	LEU A 143 LEU A 162 GLY A 179 VAL A 177 VAL A 178	None	1.27A	4yb6B-2qe6A: undetectable 4yb6F-2qe6A: undetectable	4yb6B-2qe6A: 23.31 4yb6F-2qe6A: 23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E72_A_SAMA400_1 (N2, N2-DIMETHYLGUANOSINE TRNA METHYLTRANSFERASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 4	ASP A 82 GLY A 86 ASP A 110 ASP A 135	None SAM A 400 ( 3.2A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.65A	5e72A-2qe6A: 10.8	5e72A-2qe6A: 25.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_A_RAUA400_1 (IMINE REDUCTASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 11	VAL A 177 LEU A 191 MET A 193 GLN A 229 GLY A 231	None	1.46A	5g6sA-2qe6A: 2.5 5g6sG-2qe6A: 2.5	5g6sA-2qe6A: 24.13 5g6sG-2qe6A: 24.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_B_RAUB400_1 (IMINE REDUCTASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 11	VAL A 177 LEU A 191 MET A 193 GLN A 229 GLY A 231	None	1.49A	5g6sB-2qe6A: 2.6 5g6sC-2qe6A: 2.6	5g6sB-2qe6A: 24.13 5g6sC-2qe6A: 24.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_C_RAUC400_1 (IMINE REDUCTASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLN A 229 GLY A 231 VAL A 177 LEU A 191 MET A 193	None	1.45A	5g6sB-2qe6A: 2.6 5g6sC-2qe6A: 2.6	5g6sB-2qe6A: 24.13 5g6sC-2qe6A: 24.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_E_RAUE400_1 (IMINE REDUCTASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 11	VAL A 177 LEU A 191 MET A 193 GLN A 229 GLY A 231	None	1.46A	5g6sE-2qe6A: 2.7 5g6sH-2qe6A: 2.6	5g6sE-2qe6A: 24.13 5g6sH-2qe6A: 24.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G6S_G_RAUG400_1 (IMINE REDUCTASE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 10	GLN A 229 GLY A 231 VAL A 177 LEU A 191 MET A 193	None	1.49A	5g6sA-2qe6A: 2.5 5g6sG-2qe6A: 2.6	5g6sA-2qe6A: 24.13 5g6sG-2qe6A: 24.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JI0_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 11	ILE A 160 PHE A 154 LEU A 185 ALA A 186 VAL A 136	None None None None SAM A 400 (-3.8A)	1.19A	5ji0A-2qe6A: undetectable	5ji0A-2qe6A: 23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WY0_A_SAMA800_0 (SMALL RNA 2'-O-METHYLTRANSFERA SE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ASP A 110 ILE A 111 VAL A 136	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-2.7A) SAM A 400 (-3.7A) SAM A 400 (-3.8A)	0.46A	5wy0A-2qe6A: 12.6	5wy0A-2qe6A: 23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WY0_A_SAMA800_0 (SMALL RNA 2'-O-METHYLTRANSFERA SE)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 GLY A 86 ASP A 110 VAL A 136 LEU A 169	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-2.7A) SAM A 400 (-3.8A) None	0.70A	5wy0A-2qe6A: 12.6	5wy0A-2qe6A: 23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X80_C_SALC201_1 (UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR RV2887)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 7	VAL A 240 VAL A 63 GLY A 264 TYR A 242	None None MPD A 401 (-3.2A) SO4 A 276 (-4.6A)	0.98A	5x80C-2qe6A: undetectable 5x80D-2qe6A: undetectable	5x80C-2qe6A: 21.51 5x80D-2qe6A: 21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BQ4_A_ADNA401_1 (THERMOSPERMINE SYNTHASE ACAULIS PROTEIN)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 12	GLY A 84 ASP A 110 ILE A 111 ASP A 112 ASP A 135	SAM A 400 (-3.4A) SAM A 400 (-2.7A) SAM A 400 (-3.7A) None SAM A 400 (-3.4A)	0.44A	6bq4A-2qe6A: 9.1	6bq4A-2qe6A: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BQ4_B_ADNB401_1 (THERMOSPERMINE SYNTHASE ACAULIS PROTEIN)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	6 / 12	GLY A 84 ASP A 110 ILE A 111 ASP A 112 VAL A 115 ASP A 135	SAM A 400 (-3.4A) SAM A 400 (-2.7A) SAM A 400 (-3.7A) None MPD A 403 ( 4.6A) SAM A 400 (-3.4A)	1.29A	6bq4B-2qe6A: 9.2	6bq4B-2qe6A: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6ECX_A_SAMA1301_1 (STIE PROTEIN)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	4 / 5	THR A 89 ARG A 61 THR A 129 ASP A 147	None SAM A 400 (-3.7A) None None	1.40A	6ecxA-2qe6A: 10.7	6ecxA-2qe6A: 23.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6I5Z_D_SAMD401_0 (O-METHYLTRANSFERASE 1)	2qe6	UNCHARACTERIZED PROTEIN TFU_2867 (Thermobifida fusca)	5 / 11	GLY A 84 GLY A 86 ASP A 110 VAL A 115 ASP A 135	SAM A 400 (-3.4A) SAM A 400 ( 3.2A) SAM A 400 (-2.7A) MPD A 403 ( 4.6A) SAM A 400 (-3.4A)	1.21A	6i5zD-2qe6A: 12.6	6i5zD-2qe6A: 20.65

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EE2_A_CHDA1150_0","ALCOHOL DEHYDROGENASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"LEU A 169;LEU A  81;MET A 165;VAL A 177;ILE A 142","None;None;SAM A 400 (-3.3A);None;None","1.38A","1ee2A-2qe6A:4.2","1ee2A-2qe6A:22.19"],["1HSG_B_MK1B902_2","HIV-1 PROTEASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A 110;GLY A  86;ASP A  82;VAL A 136;GLY A 164","SAM A 400 (-2.7A);SAM A 400 ( 3.2A);None;SAM A 400 (-3.8A);SAM A 400 (-3.5A)","0.91A","1hsgB-2qe6A:undetectable","1hsgB-2qe6A:17.93"],["1K6C_B_MK1B902_2","POL POLYPROTEIN","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A 110;GLY A  86;ASP A  82;VAL A 136;GLY A 164","SAM A 400 (-2.7A);SAM A 400 ( 3.2A);None;SAM A 400 (-3.8A);SAM A 400 (-3.5A)","0.98A","1k6cB-2qe6A:undetectable","1k6cB-2qe6A:17.41"],["1QAO_A_SAMA245_0","ERMC' METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ILE A 111;ASP A 112;ASP A 135","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);None;SAM A 400 (-3.4A)","0.38A","1qaoA-2qe6A:8.2","1qaoA-2qe6A:20.34"],["1RI4_A_SAMA299_0","MRNA CAPPING ENZYME","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ILE A 111;ASP A 135;TYR A 168","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);SAM A 400 (-3.4A);SAM A 400 ( 4.5A)","0.60A","1ri4A-2qe6A:13.7","1ri4A-2qe6A:24.04"],["2G72_B_SAMB2002_1","PHENYLETHANOLAMINE N-METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"TYR A  26;GLY A  86;ASP A 110;ASP A 135","SAM A 400 ( 3.8A);SAM A 400 ( 3.2A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.59A","2g72B-2qe6A:13.3","2g72B-2qe6A:25.17"],["2NXE_A_SAMA302_0","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A  82;GLY A  84;GLY A  86;ILE A 111;ASP A 112","None;SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);None","0.49A","2nxeA-2qe6A:11.7","2nxeA-2qe6A:25.91"],["2NXE_A_SAMA302_0","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A  82;LEU A  83;GLY A  84;GLY A  86;ASP A 112","None;None;SAM A 400 (-3.4A);SAM A 400 ( 3.2A);None","0.75A","2nxeA-2qe6A:11.7","2nxeA-2qe6A:25.91"],["2NXE_A_SAMA302_0","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A  82;LEU A  83;GLY A  84;GLY A  86;LEU A 169","None;None;SAM A 400 (-3.4A);SAM A 400 ( 3.2A);None","0.80A","2nxeA-2qe6A:11.7","2nxeA-2qe6A:25.91"],["2NXE_B_SAMB303_0","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A  82;GLY A  84;GLY A  86;ILE A 111;ASP A 112","None;SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);None","0.55A","2nxeB-2qe6A:11.7","2nxeB-2qe6A:25.91"],["2QE6_A_SAMA400_0","UNCHARACTERIZED PROTEIN TFU_2867","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",12,"ILE A  22;ALA A  23;TYR A  26;GLY A  84;GLY A  86;ILE A 111;ASP A 135;VAL A 136;ARG A 137;VAL A 163;GLY A 164;TYR A 168","SAM A 400 ( 3.7A);SAM A 400 (-3.1A);SAM A 400 ( 3.8A);SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);SAM A 400 (-3.4A);SAM A 400 (-3.8A);SAM A 400 (-4.6A);SAM A 400 (-4.2A);SAM A 400 (-3.5A);SAM A 400 ( 4.5A)","0.21A","2qe6A-2qe6A:51.6","2qe6A-2qe6A:100.00"],["2QE6_A_SAMA400_1","UNCHARACTERIZED PROTEIN TFU_2867","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",3,"ASN A  60;ARG A  61;ASP A 110","SAM A 400 ( 3.5A);SAM A 400 (-3.7A);SAM A 400 (-2.7A)","0.00A","2qe6A-2qe6A:51.6","2qe6A-2qe6A:100.00"],["2QE6_B_SAMB400_0","UNCHARACTERIZED PROTEIN TFU_2867","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",12,"ILE A  22;ALA A  23;TYR A  26;GLY A  84;GLY A  86;ILE A 111;ASP A 135;VAL A 136;ARG A 137;VAL A 163;GLY A 164;TYR A 168","SAM A 400 ( 3.7A);SAM A 400 (-3.1A);SAM A 400 ( 3.8A);SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);SAM A 400 (-3.4A);SAM A 400 (-3.8A);SAM A 400 (-4.6A);SAM A 400 (-4.2A);SAM A 400 (-3.5A);SAM A 400 ( 4.5A)","0.11A","2qe6B-2qe6A:49.4","2qe6B-2qe6A:100.00"],["2QE6_B_SAMB400_1","UNCHARACTERIZED PROTEIN TFU_2867","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",3,"ASN A  60;ARG A  61;ASP A 110","SAM A 400 ( 3.5A);SAM A 400 (-3.7A);SAM A 400 (-2.7A)","0.10A","2qe6B-2qe6A:49.4","2qe6B-2qe6A:100.00"],["2UYQ_A_SAMA1311_0","HYPOTHETICAL PROTEIN ML2640","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"GLY A  86;ASP A 110;ASP A 135;ARG A 137","SAM A 400 ( 3.2A);SAM A 400 (-2.7A);SAM A 400 (-3.4A);SAM A 400 (-4.6A)","0.47A","2uyqA-2qe6A:16.9","2uyqA-2qe6A:25.96"],["2X45_B_HSMB1160_1","ALLERGEN ARG R 1","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"VAL A 177;TYR A 181;ILE A 142;ASP A 135","None;None;None;SAM A 400 (-3.4A)","1.11A","2x45B-2qe6A:undetectable","2x45B-2qe6A:19.55"],["2X45_C_HSMC1160_1","ALLERGEN ARG R 1","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"VAL A 177;TYR A 181;ILE A 142;ASP A 135","None;None;None;SAM A 400 (-3.4A)","1.11A","2x45C-2qe6A:undetectable","2x45C-2qe6A:19.55"],["2YQZ_A_SAMA301_0","HYPOTHETICAL PROTEIN TTHA0223","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ASP A 112;ARG A 137;VAL A 163","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);None;SAM A 400 (-4.6A);SAM A 400 (-4.2A)","0.68A","2yqzA-2qe6A:9.9","2yqzA-2qe6A:25.16"],["2ZZN_A_SAMA401_0","UNCHARACTERIZED PROTEIN MJ0883","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"TYR A  26;GLY A  86;ILE A 111;ASP A 135;VAL A 136","SAM A 400 ( 3.8A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);SAM A 400 (-3.4A);SAM A 400 (-3.8A)","0.91A","2zznA-2qe6A:10.4","2zznA-2qe6A:20.23"],["3AY0_A_ADNA401_1","UNCHARACTERIZED PROTEIN MJ0883","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"TYR A  26;ASP A 110;ILE A 111;ASP A 135;VAL A 136","SAM A 400 ( 3.8A);SAM A 400 (-2.7A);SAM A 400 (-3.7A);SAM A 400 (-3.4A);SAM A 400 (-3.8A)","0.95A","3ay0A-2qe6A:3.5","3ay0A-2qe6A:20.23"],["3AY0_B_ADNB402_1","UNCHARACTERIZED PROTEIN MJ0883","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",6,"TYR A  26;GLY A  86;ASP A 110;ILE A 111;ASP A 135;VAL A 136","SAM A 400 ( 3.8A);SAM A 400 ( 3.2A);SAM A 400 (-2.7A);SAM A 400 (-3.7A);SAM A 400 (-3.4A);SAM A 400 (-3.8A)","1.06A","3ay0B-2qe6A:7.2","3ay0B-2qe6A:20.23"],["3BU1_A_HSMA301_1","LIPOCALIN","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"VAL A 177;TYR A 181;ILE A 142;ASP A 135","None;None;None;SAM A 400 (-3.4A)","1.05A","3bu1A-2qe6A:undetectable","3bu1A-2qe6A:22.05"],["3CJT_C_SAMC302_0","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A  82;GLY A  84;ASP A 110;ILE A 111;ASP A 112","None;SAM A 400 (-3.4A);SAM A 400 (-2.7A);SAM A 400 (-3.7A);None","0.44A","3cjtC-2qe6A:12.0","3cjtC-2qe6A:25.91"],["3DZY_A_9CRA463_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ILE A 160;PHE A 154;LEU A 185;ALA A 186;VAL A 136","None;None;None;None;SAM A 400 (-3.8A)","1.05A","3dzyA-2qe6A:undetectable","3dzyA-2qe6A:19.83"],["3EKT_B_017B200_1","PROTEASE;PROTEASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A 110;GLY A  86;ASP A  82;VAL A 136;GLY A 164","SAM A 400 (-2.7A);SAM A 400 ( 3.2A);None;SAM A 400 (-3.8A);SAM A 400 (-3.5A)","1.03A","3ektA-2qe6A:undetectable","3ektA-2qe6A:17.05"],["3GRV_A_ADNA300_1","DIMETHYLADENOSINE TRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ILE A 111;ASP A 112;ASP A 135","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);None;SAM A 400 (-3.4A)","0.71A","3grvA-2qe6A:9.3","3grvA-2qe6A:22.19"],["3O7W_A_SAMA801_0","LEUCINE CARBOXYL METHYLTRANSFERASE 1","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ASP A 135;ARG A 137;TYR A 168","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.4A);SAM A 400 (-4.6A);SAM A 400 ( 4.5A)","0.39A","3o7wA-2qe6A:16.1","3o7wA-2qe6A:24.02"],["3OU6_B_SAMB300_1","SAM-DEPENDENT METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",3,"TYR A  26;ASP A 110;ASP A 135","SAM A 400 ( 3.8A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.70A","3ou6B-2qe6A:13.4","3ou6B-2qe6A:23.57"],["3OU6_C_SAMC300_1","SAM-DEPENDENT METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",3,"TYR A  26;GLY A  86;ASP A 110","SAM A 400 ( 3.8A);SAM A 400 ( 3.2A);SAM A 400 (-2.7A)","0.72A","3ou6C-2qe6A:13.3","3ou6C-2qe6A:23.57"],["3OU7_C_SAMC300_1","SAM-DEPENDENT METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",3,"GLY A  86;ASP A 110;ASP A 135","SAM A 400 ( 3.2A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.33A","3ou7C-2qe6A:13.2","3ou7C-2qe6A:23.57"],["3OXW_B_017B200_1","HIV-1 PROTEASE;HIV-1 PROTEASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A 110;GLY A  86;ASP A  82;VAL A 136;GLY A 164","SAM A 400 (-2.7A);SAM A 400 ( 3.2A);None;SAM A 400 (-3.8A);SAM A 400 (-3.5A)","0.97A","3oxwA-2qe6A:undetectable","3oxwA-2qe6A:15.58"],["3SJ4_X_DXCX75_0","CYTOCHROME C7","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ILE A 160;LEU A 185;ILE A 268;PHE A 233;GLY A 231","None","1.16A","3sj4X-2qe6A:undetectable","3sj4X-2qe6A:12.34"],["3V8V_B_SAMB801_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  86;ASP A 110;ASP A 112;ASP A 135;VAL A 136","SAM A 400 ( 3.2A);SAM A 400 (-2.7A);None;SAM A 400 (-3.4A);SAM A 400 (-3.8A)","0.86A","3v8vB-2qe6A:10.1","3v8vB-2qe6A:17.35"],["4DQC_A_017A101_2","ASPARTYL PROTEASE;ASPARTYL PROTEASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A 110;GLY A  86;ASP A  82;VAL A 136;GLY A 164","SAM A 400 (-2.7A);SAM A 400 ( 3.2A);None;SAM A 400 (-3.8A);SAM A 400 (-3.5A)","1.00A","4dqcB-2qe6A:undetectable","4dqcB-2qe6A:16.73"],["4HB8_A_DXCA75_0","PPCA","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ILE A 160;LEU A 185;ILE A 268;PHE A 233;GLY A 231","None","1.25A","4hb8A-2qe6A:undetectable","4hb8A-2qe6A:11.72"],["4IV0_A_SAMA302_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE, PUTATIVE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"VAL A 148;GLY A  84;ILE A 160;ARG A 137;LEU A 143","None;SAM A 400 (-3.4A);None;SAM A 400 (-4.6A);None","1.04A","4iv0A-2qe6A:14.2","4iv0A-2qe6A:20.79"],["4IV8_A_SAMA301_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE,PUTATIVE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ASP A 110;ILE A 111;ASP A 135","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-2.7A);SAM A 400 (-3.7A);SAM A 400 (-3.4A)","0.47A","4iv8A-2qe6A:14.1","4iv8A-2qe6A:22.30"],["4IV8_B_SAMB301_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE,PUTATIVE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ASP A 110;ILE A 111;ASP A 135","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-2.7A);SAM A 400 (-3.7A);SAM A 400 (-3.4A)","0.48A","4iv8B-2qe6A:14.1","4iv8B-2qe6A:22.30"],["4KIC_A_SAMA401_0","METHYLTRANSFERASE MPPJ","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ILE A 111;ARG A 137;MET A 165","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);SAM A 400 (-4.6A);SAM A 400 (-3.3A)","0.66A","4kicA-2qe6A:15.0","4kicA-2qe6A:24.59"],["4KIC_B_SAMB401_0","METHYLTRANSFERASE MPPJ","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ILE A 111;ARG A 137;MET A 165","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-3.7A);SAM A 400 (-4.6A);SAM A 400 (-3.3A)","0.65A","4kicB-2qe6A:15.2","4kicB-2qe6A:24.59"],["4LB2_A_DM5A602_1","SERUM ALBUMIN","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"PRO A 238;VAL A 241;ALA A 266;TYR A 190","None","0.89A","4lb2A-2qe6A:undetectable","4lb2A-2qe6A:18.87"],["4MA7_A_P2ZA301_1","MAJOR PRION PROTEIN","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"VAL A 109;LEU A  83;TYR A 181;VAL A 173","None","0.98A","4ma7A-2qe6A:undetectable","4ma7A-2qe6A:17.20"],["4MBS_B_MRVB1101_2","CHIMERA PROTEIN OF C-C CHEMOKINE RECEPTOR TYPE 5 AND RUBREDOXIN","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"TYR A  26;THR A 129;LEU A 123;MET A 114","SAM A 400 ( 3.8A);None;MPD A 403 (-4.2A);None","1.21A","4mbsB-2qe6A:undetectable","4mbsB-2qe6A:21.93"],["4MWZ_B_SAMB301_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE, PUTATIVE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"VAL A 148;GLY A  84;ILE A 160;ARG A 137;LEU A 143","None;SAM A 400 (-3.4A);None;SAM A 400 (-4.6A);None","1.05A","4mwzB-2qe6A:14.0","4mwzB-2qe6A:20.33"],["4NJT_B_017B101_2","PROTEASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A 110;GLY A  86;ASP A  82;VAL A 136;GLY A 164","SAM A 400 (-2.7A);SAM A 400 ( 3.2A);None;SAM A 400 (-3.8A);SAM A 400 (-3.5A)","1.01A","4njtB-2qe6A:undetectable","4njtB-2qe6A:16.67"],["4PGH_B_SAMB401_0","CAFFEIC ACID O-METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ASP A  82;GLY A  84;THR A  93;ASP A 110;ASP A 135","None;SAM A 400 (-3.4A);None;SAM A 400 (-2.7A);SAM A 400 (-3.4A)","1.18A","4pghB-2qe6A:12.5","4pghB-2qe6A:22.07"],["4XV2_A_P06A801_2","SERINE\/THREONINE-PROTEIN KINASE B-RAF","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"GLY A 164;LEU A  71;PHE A  70;ILE A 268","SAM A 400 (-3.5A);None;None;None","0.80A","4xv2A-2qe6A:undetectable","4xv2A-2qe6A:21.45"],["4YB6_A_HISA302_0","ATP PHOSPHORIBOSYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A 179;VAL A 177;VAL A 178;LEU A 143;LEU A 162","None","1.26A","4yb6A-2qe6A:undetectable;4yb6E-2qe6A:undetectable","4yb6A-2qe6A:23.31;4yb6E-2qe6A:23.31"],["4YB6_B_HISB302_0","ATP PHOSPHORIBOSYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A 179;VAL A 177;VAL A 178;LEU A 143;LEU A 162","None","1.27A","4yb6B-2qe6A:undetectable;4yb6C-2qe6A:undetectable","4yb6B-2qe6A:23.31;4yb6C-2qe6A:23.31"],["4YB6_F_HISF302_0","ATP PHOSPHORIBOSYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"LEU A 143;LEU A 162;GLY A 179;VAL A 177;VAL A 178","None","1.27A","4yb6B-2qe6A:undetectable;4yb6F-2qe6A:undetectable","4yb6B-2qe6A:23.31;4yb6F-2qe6A:23.31"],["5E72_A_SAMA400_1","N2, N2-DIMETHYLGUANOSINE TRNA METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"ASP A  82;GLY A  86;ASP A 110;ASP A 135","None;SAM A 400 ( 3.2A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.65A","5e72A-2qe6A:10.8","5e72A-2qe6A:25.92"],["5G6S_A_RAUA400_1","IMINE REDUCTASE;IMINE REDUCTASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"VAL A 177;LEU A 191;MET A 193;GLN A 229;GLY A 231","None","1.46A","5g6sA-2qe6A:2.5;5g6sG-2qe6A:2.5","5g6sA-2qe6A:24.13;5g6sG-2qe6A:24.13"],["5G6S_B_RAUB400_1","IMINE REDUCTASE;IMINE REDUCTASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"VAL A 177;LEU A 191;MET A 193;GLN A 229;GLY A 231","None","1.49A","5g6sB-2qe6A:2.6;5g6sC-2qe6A:2.6","5g6sB-2qe6A:24.13;5g6sC-2qe6A:24.13"],["5G6S_C_RAUC400_1","IMINE REDUCTASE;IMINE REDUCTASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLN A 229;GLY A 231;VAL A 177;LEU A 191;MET A 193","None","1.45A","5g6sB-2qe6A:2.6;5g6sC-2qe6A:2.6","5g6sB-2qe6A:24.13;5g6sC-2qe6A:24.13"],["5G6S_E_RAUE400_1","IMINE REDUCTASE;IMINE REDUCTASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"VAL A 177;LEU A 191;MET A 193;GLN A 229;GLY A 231","None","1.46A","5g6sE-2qe6A:2.7;5g6sH-2qe6A:2.6","5g6sE-2qe6A:24.13;5g6sH-2qe6A:24.13"],["5G6S_G_RAUG400_1","IMINE REDUCTASE;IMINE REDUCTASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLN A 229;GLY A 231;VAL A 177;LEU A 191;MET A 193","None","1.49A","5g6sA-2qe6A:2.5;5g6sG-2qe6A:2.6","5g6sA-2qe6A:24.13;5g6sG-2qe6A:24.13"],["5JI0_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"ILE A 160;PHE A 154;LEU A 185;ALA A 186;VAL A 136","None;None;None;None;SAM A 400 (-3.8A)","1.19A","5ji0A-2qe6A:undetectable","5ji0A-2qe6A:23.91"],["5WY0_A_SAMA800_0","SMALL RNA 2'-O-METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ASP A 110;ILE A 111;VAL A 136","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-2.7A);SAM A 400 (-3.7A);SAM A 400 (-3.8A)","0.46A","5wy0A-2qe6A:12.6","5wy0A-2qe6A:23.78"],["5WY0_A_SAMA800_0","SMALL RNA 2'-O-METHYLTRANSFERASE","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ASP A 110;VAL A 136;LEU A 169","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-2.7A);SAM A 400 (-3.8A);None","0.70A","5wy0A-2qe6A:12.6","5wy0A-2qe6A:23.78"],["5X80_C_SALC201_1","UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR RV2887;UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR RV2887","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"VAL A 240;VAL A  63;GLY A 264;TYR A 242","None;None;MPD A 401 (-3.2A);SO4 A 276 (-4.6A)","0.98A","5x80C-2qe6A:undetectable;5x80D-2qe6A:undetectable","5x80C-2qe6A:21.51;5x80D-2qe6A:21.51"],["6BQ4_A_ADNA401_1","THERMOSPERMINE SYNTHASE ACAULIS PROTEIN","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;ASP A 110;ILE A 111;ASP A 112;ASP A 135","SAM A 400 (-3.4A);SAM A 400 (-2.7A);SAM A 400 (-3.7A);None;SAM A 400 (-3.4A)","0.44A","6bq4A-2qe6A:9.1","6bq4A-2qe6A:12.50"],["6BQ4_B_ADNB401_1","THERMOSPERMINE SYNTHASE ACAULIS PROTEIN","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",6,"GLY A  84;ASP A 110;ILE A 111;ASP A 112;VAL A 115;ASP A 135","SAM A 400 (-3.4A);SAM A 400 (-2.7A);SAM A 400 (-3.7A);None;MPD A 403 ( 4.6A);SAM A 400 (-3.4A)","1.29A","6bq4B-2qe6A:9.2","6bq4B-2qe6A:12.50"],["6ECX_A_SAMA1301_1","STIE PROTEIN","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",4,"THR A  89;ARG A  61;THR A 129;ASP A 147","None;SAM A 400 (-3.7A);None;None","1.40A","6ecxA-2qe6A:10.7","6ecxA-2qe6A:23.55"],["6I5Z_D_SAMD401_0","O-METHYLTRANSFERASE 1","2qe6","UNCHARACTERIZED PROTEIN TFU_2867","Thermobifida fusca",5,"GLY A  84;GLY A  86;ASP A 110;VAL A 115;ASP A 135","SAM A 400 (-3.4A);SAM A 400 ( 3.2A);SAM A 400 (-2.7A);MPD A 403 ( 4.6A);SAM A 400 (-3.4A)","1.21A","6i5zD-2qe6A:12.6","6i5zD-2qe6A:20.65"]]